FTC Seeks Pause Of $28B Amgen Deal Amid Challenge
The Federal Trade Commission has asked an Illinois federal court to issue a preliminary injunction preventing Amgen and Horizon Therapeutics from closing their planned $27.8 billion merger before an administrative case...To view the full article, register now.
Already a subscriber? Click here to view full article